Li D - Search Results

1

Global, regional, and national burden of acute myeloid leukemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.

Zhou Y, Huang G, Cai X, Liu Y, Qian B, Li D. Zhou Y, et al. Among authors: li d. Biomark Res. 2024 Sep 11;12(1):101. doi: 10.1186/s40364-024-00649-y. Biomark Res. 2024. PMID: 39256810 Free PMC article.

2

Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study.

Ning L, Hu C, Lu P, Que Y, Zhu X, Li D. Ning L, et al. Among authors: li d. Exp Hematol Oncol. 2020 Nov 3;9(1):29. doi: 10.1186/s40164-020-00185-z. Exp Hematol Oncol. 2020. PMID: 33292593 Free PMC article.

3

XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway.

Cai X, Liu Y, Li H, Que Y, Xiao M, Wang Y, Wang X, Li D. Cai X, et al. Among authors: li d, li h. Ann Hematol. 2024 Jul;103(7):2311-2322. doi: 10.1007/s00277-024-05706-y. Epub 2024 Mar 23. Ann Hematol. 2024. PMID: 38519605

4

Significance of targeting DNMT3A mutations in AML.

Huang G, Cai X, Li D. Huang G, et al. Among authors: li d. Ann Hematol. 2024 Jul 30. doi: 10.1007/s00277-024-05885-8. Online ahead of print. Ann Hematol. 2024. PMID: 39078434 Review.

5

Short-Course Blinatumomab Treatment as a Bridge to Further Salvage Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A Retrospective Single-Center Study.

Yin J, Cai X, Qian B, Liu Y, Li D. Yin J, et al. Among authors: li d. Cancer Med. 2024 Dec;13(24):e70515. doi: 10.1002/cam4.70515. Cancer Med. 2024. PMID: 39692275 Free PMC article.

6

Prognosis of Patients With de novo Acute Myeloid Leukemia Resistant to Initial Induction Chemotherapy.

Wu S, Yang S, Zhu L, Wang Y, Zhang Y, Zhou J, Li D. Wu S, et al. Among authors: li d. Am J Med Sci. 2016 May;351(5):473-9. doi: 10.1016/j.amjms.2016.02.034. Epub 2016 Mar 2. Am J Med Sci. 2016. PMID: 27140705

7

The Prognostic Value of D-Dimer in De Novo Acute Myeloid Leukemia.

Geng Y, Jian C, Yang S, Wu S, Zhou J, Li D. Geng Y, et al. Among authors: li d. Am J Med Sci. 2016 Aug;352(2):129-33. doi: 10.1016/j.amjms.2016.04.008. Epub 2016 Apr 25. Am J Med Sci. 2016. PMID: 27524209

8

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.

Hu X, Cai H, Zheng L, Luo Y, Zhou J, Hui Y, Dai Z, Lin H, Li D, Xiao Y, Huang L, Zhou J. Hu X, et al. Among authors: li d. Cancer Med. 2020 Jul;9(14):4941-4948. doi: 10.1002/cam4.3140. Epub 2020 May 18. Cancer Med. 2020. PMID: 32419364 Free PMC article.

9

Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway.

Lin L, Que Y, Lu P, Li H, Xiao M, Zhu X, Li D. Lin L, et al. Among authors: li d, li h. Front Pharmacol. 2020 Oct 19;11:569651. doi: 10.3389/fphar.2020.569651. eCollection 2020. Front Pharmacol. 2020. PMID: 33192510 Free PMC article.

10

Exploring the determinants that influence hospital costs of induction therapy for acute myeloid leukemia.

Ning L, Li D, Lu P, Que Y. Ning L, et al. Among authors: li d. Leuk Lymphoma. 2021 May;62(5):1211-1218. doi: 10.1080/10428194.2020.1855339. Epub 2020 Dec 10. Leuk Lymphoma. 2021. PMID: 33300383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,762 results

Search Page

Filters